The mammalian target of rapamycin inhibitor RAD001 (everolimus) synergizes with chemotherapeutic agents, ionizing radiation and proteasome inhibitors in pre-B acute lymphocytic leukemia

Philip O. Saunders(Westmead Institute), Linda J. Bendall(The University of Sydney)

Haematologica

October 15, 2010

10.3324/haematol.2010.026997

Cited by 60

Related Papers

Interaction of interleukin-7 and interleukin-3 with the CXCL12-induced proliferation of B-cell progenitor acute lymphoblastic leukemia

|Haematologica|2007|57

mTOR Inhibition by Everolimus in Childhood Acute Lymphoblastic Leukemia Induces Caspase-Independent Cell Death

|PLoS ONE|2014|33

Silencer of Death Domains Controls Cell Death through Tumour Necrosis Factor-Receptor 1 and Caspase-10 in Acute Lymphoblastic Leukemia

|PLoS ONE|2014|12